Skip to content

Genetesis, Inc.

Country not established

Devices
1

What Genetesis, Inc. makes

Genetesis, Inc. manufactures the CardioFlux system, a medical device paired with Faraday Analytical Cloud for diagnostic analysis, likely focused on cardiovascular monitoring or signal processing.

The company’s portfolio is regulated under FDA’s Class II device classification, with the CardioFlux system listed via the 510(k) clearance pathway. The manufacturer is based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

Frequently asked questions

How many devices does Genetesis, Inc. have in the registry?

The registry currently lists 1 device for Genetesis, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Genetesis, Inc.'s devices?

Among its 1 most recently registered device, Genetesis, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Genetesis, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Genetesis, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Genetesis, Inc. in the registry?

The most recently registered devices listed for Genetesis, Inc. include CardioFlux with Faraday Analytical Cloud.

Generated automatically from registry data and not verified by a human reviewer.